NANOG and dysgerminoma: Expression of the stem cell-related markers OCT-3/4 and KIT were present in 80% of dysgerminomas, 75–100% of tumours containing gonadoblastoma and in two yolk sac tumours, whereas NANOG and AP-2γ were present in approximately half of the dysgerminomas and gonadoblastomas.